alex@fookcommunications.com, Author at Wittington Ventures

Revolutionizing Pharma Sales Enablement with AI: Our Investment in Odaia Posted on May 1, 2023 (June 23, 2023) by alex@fookcommunications.com in Healthcare
Smaller Trials, Bigger Impact: Transforming Clinical Trials with Unlearn’s AI-powered Digital Twins Posted on March 27, 2023 (June 23, 2023) by alex@fookcommunications.com in Healthcare
Introducing WV’s Investment in Brave: An impactful business poised for growth Posted on October 12, 2022 (June 23, 2023) by alex@fookcommunications.com in Healthcare
Introducing WV’s Investment in Abridge Posted on August 11, 2022 (May 19, 2023) by alex@fookcommunications.com in Uncategorized
Now We’re Cooking: My Path to Wittington Ventures Posted on March 8, 2022 (August 14, 2023) by alex@fookcommunications.com in Uncategorized
Exploring Social Commerce Posted on December 16, 2021 (May 19, 2023) by alex@fookcommunications.com in Uncategorized
From Lab to Launch: How Clinical Trial Management Systems are Keeping Discovery Moving Posted on November 18, 2021 (May 19, 2023) by alex@fookcommunications.com in Uncategorized
Arcaea: Re-Imagining the Beauty Industry through Expressive Biology Posted on October 27, 2021 (May 19, 2023) by alex@fookcommunications.com in Uncategorized
Testing 1,2,3: Introducing WV’s Investment in Truvian Posted on February 24, 2021 (May 19, 2023) by alex@fookcommunications.com in Uncategorized
Foxtrot Market: A blueprint for retail in an omnichannel world Posted on February 22, 2021 (June 23, 2023) by alex@fookcommunications.com in Commerce
Connected Health — what’s getting us excited at Wittington Ventures Posted on January 26, 2021 (June 23, 2023) by alex@fookcommunications.com in Healthcare